Comparison of insulin degludec with insulin glargine in insulin‐naive subjects with Type 2 diabetes: a 2‐year randomized, treat‐to‐target trial - Rodbard - 2013 - Diabetic Medicine - Wiley Online Library
Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin | SpringerLink
Insulin degludec: Uses, Interactions, Mechanism of Action | DrugBank Online
Structure (A) and mechanism of protraction (B) of insulin degludec... | Download Scientific Diagram
What is Tresiba (Insulin Degludec) Used For and How Does It Work?
Simulated insulin degludec (IDeg) concentration–time profiles at steady... | Download Scientific Diagram
Insulin degludec, a new generation ultra-long acting insulin, used once daily or 3-times weekly in people with type 2 diabetes: comparison to insulin glargine - Virtual Meeting | EASD
Frontiers | Use of Insulin Degludec/Insulin Aspart in the Management of Diabetes Mellitus: Expert Panel Recommendations on Appropriate Practice Patterns | Endocrinology
Insulin degludec, a new generation ultra-long acting insulin, used once daily or 3-times weekly in people with type 2 diabetes: comparison to insulin glargine - Virtual Meeting | EASD
Insulin degludec, an ultra-long-acting basal insulin, once a ... - NATAP
Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes – topic of research paper in Medical engineering. Download scholarly article PDF
CIMB | Free Full-Text | Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons | HTML
Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function | Cardiovascular Diabetology | Full Text
Clinical use of insulin degludec - Diabetes Research and Clinical Practice
Insulin analogues in type 1 diabetes mellitus: getting better all the time | Nature Reviews Endocrinology
Insulin degludec - Wikipedia
Schematic representations of (a) insulin degludec composition, (b)... | Download Scientific Diagram
New Insulin Formulations - ppt video online download
Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2
CIMB | Free Full-Text | Proteomic Changes to the Updated Discovery of Engineered Insulin and Its Analogs: Pros and Cons | HTML
PDF) Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: A 16-week, randomised, open-label, phase
PDF) Insulin degludec: A novel ultra-acting basal insulin: Potential usefulness in hospitalized patients
Insulin degludec - wikidoc
